Walk in interview for M.Pharm, M.Sc as Associate/ Senior Associate at STELIS Biopharma
STELIS Biopharma Pvt. Ltd. is a fully-owned subsidiary of Strides set up in 2013 to consolidate and augment the R&D activities of Inbiopro, which was fully acquired in 2012; and in extending the value chain to manufacturing and commercialisation of the product pipeline. STELIS is pursuing a blended strategy of- developing both ‘biosimilars’ and ‘novel biotherapeutics’ to a ‘Regulated’ market (US/EU) standard for global markets. Our strategy is to offer high-quality bio-pharmaceuticals at affordable prices initially in high-growth Emerging Markets whose vast patient populations offer un-paralleled opportunities for expanded access.